Related Experiment Video
Updated: Aug 6, 2026
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
[Assessment of six drug sensitivities in established cell lines of SO-Rb50 and SO-Rb70]
1Zhongshan Ophthalmic Center, Sun Yat-sen University of Medical Sciences, Guangzhou 510060.
Objective:
With retinoblastoma (Rb) cell lines cultured in vitro to screen chemotherapeutic drugs that are effective on Rb.
Method:
Sensitivity experiments were performed with the 3, -4, 5 Dimethyliazol-2, 5 diphenyl tetrazolium bromide (MTT) assay for the drugs: dactinomycin (DACT), vincristine (VCR), VM-26, daunorubicin (DNR), DDP, bleomycin (BLMA5) against the tumor cell lines of SO-Rb50 and SO-Rb70.
Results:
The IC(50) values (microg/ml) in order at 48 hours of the above pharmaceuticals against SO-Rb50 were respectively 0.0004, 0.0016, 0.0389, 0.047, 0.29, 0.44, and those at 72 hours were 0.00025, 0.00081, 0.0151, 0.0192, 0.097, 0.11. And the IC(50) values (microg/ml) in order at 48 hours of the above pharmaceuticals against SO-Rb70 were respectively 0.00065, 0.00149, 0.0282, 0.043, 0.37, 0.215, and those at 72 hours were 0.00042, 0.00082, 0.0146, 0.0176, 0.035, 0.084.
Conclusion:
The tumor cell lines of SO-Rb50 and SO-Rb70 were sensitive to the above six pharmaceuticals. By their IC(50) values, the sensitivity order to the drugs, from higher to lower, was DACT, VCR, VM-26, DNR, DDP, BLMA5.
Insights
Retinoblastoma cell lines showed sensitivity to dactinomycin, vincristine, VM-26, daunorubicin, DDP, and bleomycin. Dactinomycin was the most effective chemotherapeutic drug against these retinoblastoma models.
Area of Science:
- Oncology
- Pharmacology
- Cell Biology
Context:
- Retinoblastoma (Rb) is a pediatric eye cancer.
- In vitro models are crucial for drug screening.
- Identifying effective chemotherapeutic agents is a priority in Rb treatment.
Purpose:
- To screen chemotherapeutic drugs for efficacy against retinoblastoma (Rb) cell lines.
- To determine the sensitivity of SO-Rb50 and SO-Rb70 cell lines to various drugs.
- To establish a comparative sensitivity ranking of tested drugs.
Summary:
- Sensitivity experiments utilized the MTT assay on SO-Rb50 and SO-Rb70 retinoblastoma cell lines.
- Drugs tested included dactinomycin (DACT), vincristine (VCR), VM-26, daunorubicin (DNR), DDP, and bleomycin (BLMA5).
- IC(50) values were determined at 48 and 72 hours, revealing differential drug sensitivity.
Impact:
- The study identified dactinomycin (DACT) as the most potent drug against both Rb cell lines.
- A clear hierarchy of drug sensitivity was established: DACT > VCR > VM-26 > DNR > DDP > BLMA5.
- These findings provide a basis for further preclinical and clinical investigations of these agents in retinoblastoma treatment.
More Related Videos
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
10:24Identification of Potential Anti-TB Candidates: A Step-by-Step Guide to Synthesis, MIC Determination, and Cytotoxicity Assessment in Mammalian Cells
Published on: May 22, 2026